dimebon

The billion-dollar gamble: Biotech CEO takes a risky second shot at an Alzheimer’s drug
Stat
Thu, 09/7/17 - 09:35 am
Alzheimer's disease
Axovant
David Hung
dimebon
Medivation
intepirdine
Show me the money: Which drugs made the top 10 list on upfront deals?
Fierce Biotech
Mon, 05/12/14 - 09:36 am
biotech
GED-0301
Celgene
Nogra Pharma
AbbVie
Reata
Bardoxolone
Abbott Labs
Tradjenta
Eli Lilly
Boehringer Ingelheim
FG-4592
AstraZeneca
FibroGen
Pfizer
Bristol-Myers Squibb
Eliquis
Moderna
Forma Therapeutics
dimebon
Medivation
Jakafi
Novartis
Incyte
Pfizer, Medivation end development of potential Alzheimer's treatment dimebon
Yahoo/AP
Tue, 01/17/12 - 10:06 am
Pfizer
Medivation
Alzheimer's disease
dimebon
3 Cancer-Fighting Stocks That Could Deliver Huge Gains
Seeking Alpha
Sat, 10/8/11 - 11:46 am
ThermoDox
Celsion
liver cancer
Threshold Pharmaceuticals
TH-302
leukemia
Medivation
dimebon
Alzheimer's disease
MDV3100
prostate cancer
Pfizer
Medivation Remains Neutral
Yahoo/Zacks.com
Tue, 09/13/11 - 10:15 am
Medivation
JNJ
Pfizer
dimebon
Alzheimer's disease
prostate cancer
MDV3100
Abiraterone vs. MDV3100: A prostate cancer drug showdown
Fierce Biotech
Thu, 05/19/11 - 02:08 pm
abiraterone
prostate cancer
Medivation
MDV3100
dimebon
Pfizer
Astellas
Medivation Shares Popped: What You Need to Know
Motley Fool
Sat, 04/30/11 - 09:56 am
Medivation
MDV3100
prostate cancer
Alzheimer's disease
dimebon
Medivation/Pfizer drug fails late-stage Huntington's disease trial
Bizjournals.com
Mon, 04/11/11 - 11:36 am
Huntington's disease
Pfizer
Medivation
dimebon
The Top 10 Phase III Failures of 2010
Fierce Biotech
Fri, 10/22/10 - 11:36 am
clinical trials
dimebon
Medivation
Pfizer
ocrelizumab
Roche
rheumatoid arthritis
taspoglutide
diabetes
Ipsen
semagacestat
Eli Lilly
ASA404
Antisoma
Novartis
Novelos Therapeutics
AstraZeneca
zibotentan
vicriviroc
Merck
Recentin
Vical
Sanofi
Finkelstein Thompson LLP Announces Investigation of Medivation, Inc.
Yahoo/Business Wire
Sat, 04/10/10 - 12:18 pm
Medivation
dimebon
Alzheimer's disease
investors
Pfizer's 3 Points of Failure
Motley Fool
Sat, 03/13/10 - 10:34 am
Pfizer
Sutent
dimebon
figitumumab
Lesson from an Alzheimer-Drug Failure: Beware Russian Clinical Trial Data
BNET Pharma
Mon, 03/8/10 - 10:13 am
Russia
clinical trials
Alzheimer's disease
dimebon
Medivation
Pfizer
A Ray Of Hope For Medivation
Forbes
Thu, 03/4/10 - 06:04 pm
Medivation
Pfizer
Alzheimer's disease
dimebon
Drug stocks climb; Medivation sinks on drug study
Marketwatch
Wed, 03/3/10 - 11:56 am
Medivation
dimebon
drug stocks
Pfizer
Pfizer, Medivation’s Drug Fails in Alzheimer’s Study
Bloomberg
Wed, 03/3/10 - 11:43 am
Pfizer
Medivation
dimebon
Alzheimer's disease
Pfizer's New Alzheimer's Drug: A Black Box Indeed
Seeking Alpha
Thu, 02/4/10 - 09:45 am
Pfizer
black box
Alzheimer's disease
dimebon
Medivation's Alzheimer Trial Data in Early March
TheStreet.com
Tue, 02/2/10 - 11:10 am
Alzheimer's disease
drug trials
Medivation
Pfizer
dimebon
Mystery Alzheimer’s Drug May Yield Advance for Pfizer
Bloomberg
Tue, 02/2/10 - 10:28 am
Pfizer
Alzheimer's disease
dimebon
Medivation starts Phase III study for Huntington's
Marketwatch
Thu, 07/30/09 - 09:20 am
Medivation
drug trials
Huntington's disease
dimebon
An Alzheimer's Drug Mystery
Forbes
Wed, 07/15/09 - 10:01 am
Alzheimer's disease
Medivation
dimebon